A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...

HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Even now — decades after the virus was identified — and with antiretroviral drugs allowing us to ...

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

That scientific creativity helped propel her to being named a top 40 finalist in the 84th Regeneron Science Talent Search — ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

Let’s face it. The Philippines, a predominantly Catholic country, has a major problem with teen pregnancies and a steadily rising rate of HIV infection. One in 10 female teenagers below 15 years of ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...